5//SEC Filing
Gorlach Jorn 5
Accession 0001388410-19-000012
CIK 0001388410other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 2:23 PM ET
Size
8.0 KB
Accession
0001388410-19-000012
Insider Transaction Report
Form 5
Gorlach Jorn
Director10% Owner
Transactions
- Award
PREFERRED STOCK (SERIES B)
2017-01-23$5.00/sh+30,000$150,000→ 393,393 total(indirect: By Hamburg Investment Co)Exercise: $0.25From: 2017-01-23Exp: 2019-01-23→ COMMON STOCK (600,000 underlying) - Award
WARRANTS (PREFERRED SERIES B)
2017-01-23+15,000→ 408,393 total(indirect: By Hamburg Investment Co)Exercise: $0.75From: 2017-01-23Exp: 2019-01-23→ COMMON STOCK (300,000 underlying)
Footnotes (1)
- [F1]Pursuant to Conversion Rights, holders of Series B Convertible Preferred Stock may elect to convert their shares at the then Conversion Ratio at any time in whole or in part for a period of two years from the date of purchase.
Documents
Issuer
PARALLAX HEALTH SCIENCES, INC.
CIK 0001388410
Entity typeother
Related Parties
1- filerCIK 0001596048
Filing Metadata
- Form type
- 5
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 2:23 PM ET
- Size
- 8.0 KB